Related Experiment Videos
Third ventriculostomy for hydrocephalus associated with spinal dysraphism: indications and contraindications
R F Jones1, B C Kwok, W A Stening
1Sydney Children's Hospital, Australia.
Summary
Endoscopic third ventriculostomy shows promise, especially in patients with prior shunts. However, success rates are lower in infants under six months, suggesting age and prior treatments impact outcomes for hydrocephalus management.
Area of Science:
- Neurosurgery
- Pediatric Neurosurgery
- Hydrocephalus Research
Background:
- Endoscopic third ventriculostomy (ETV) is a neurosurgical procedure.
- Hydrocephalus management often involves cerebrospinal fluid (CSF) shunting.
- ETV offers an alternative or adjunct to shunting.
Purpose of the Study:
- To evaluate the efficacy of ETV in a specific patient cohort.
- To compare ETV outcomes in patients with and without prior CSF shunting.
- To identify factors influencing ETV success in hydrocephalus.
Main Methods:
- Retrospective analysis of 25 patients undergoing ETV.
- Comparison of outcomes based on age (under 6 months vs. older).
- Assessment of ETV success in patients with prior shunt revisions versus initial ETV.
Main Results:
- 13 out of 14 patients with prior shunts had long-term success with ETV.
- Only 1 out of 11 patients under 6 months achieved long-term success.
- Patients with prior shunts demonstrated better CSF-resorptive capability.
Conclusions:
- ETV can be successful, particularly in patients with established CSF shunts.
- Younger infants (<6 months) have poorer outcomes, possibly due to impaired CSF absorption.
- Prior CSF diversion may influence the development of CSF absorptive pathways.